Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119400 · ClinicalTrials.gov registry record
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT05119400 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 2 participants.
The verdict
NCT05119400 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The goal of this longitudinal and observational study is to better understand the psychiatric consequences of COVID-19 over time. Psychiatric outcomes like mood, anxiety, stress, and cognitive symptoms in patients who underwent inpatient hospitalization at NewYork-Presbyterian Hospital/Weill Cornell Medicine for COVID-19 will be assessed at 6 months or later post-discharge.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2024-04-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05119400
The ClinicalTrials.gov registry entry for NCT05119400 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05119400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05119400 about?
NCT05119400 is a clinical study titled "COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes". The goal of this longitudinal and observational study is to better understand the psychiatric consequences of COVID-19 over time. Psychiatric outcomes like mood, anxiety, stress, and cognitive symptoms in patients who underwent inpatient hospitalization at NewYork-Presbyterian Hospital/Weill Cornell...
What is the current status of trial NCT05119400?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2021-12-17. Estimated completion is 2024-04-02.
Who is sponsoring clinical trial NCT05119400?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.